Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ORGANON

  • FDA Approval
  • Oct. 29, 2024, 17:28 UTC
  • 59
  • 0 comments

FDA approve ATORVASTATIN CALCIUM; EZETIMIBE

Comment Full text

APOTEX

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 57
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

ALEMBIC

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 59
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

NOVAST LABS

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 61
  • 0 comments

FDA approve PRAMIPEXOLE DIHYDROCHLORIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 60
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

AM REGENT

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 58
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 58
  • 0 comments

FDA approve EZETIMIBE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 59
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MAYNE PHARMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 55
  • 0 comments

FDA approve ITRACONAZOLE

Comment Full text

SHANDONG XINHUA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 61
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text
  • Previous
  • 325
  • 326
  • 327
  • 328
  • 329
  • Next

Search

News categories

  • Technical Exchange News(14648)
  • Event(6229)
  • SEC News(388752)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237588)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin